OAR 332-026-0020: Approved Legend Drugs For Neonatal Use

Edition: Current OARD snapshotEffective: 2020-01-01Last verified: 2026-09-07

An LDM may administer the following legend drugs as approved by the Board for neonatal use: (1) Eye Prophylaxis for disease of the newborn is limited to Erythromycin Ophthalmic (0.5%) Ointment (Ilotycin, AK-Mycin and generics). (2) Prophylaxis for hemorrhagic disease of the newborn for oral use is limited to Mephyton. (3) Prophylaxis for hemorrhagic disease of the newborn for intramuscular injection includes: (a) AquaMephyton; and (b) Konakion. (4) Resuscitation is limited to medical oxygen.

Official history and status

Statutory/Other Authority: ORS 676.615 & ORS 687.493

Statutes/Other Implemented: ORS 687.493

History: DEM 3-2019, amend filed 12/19/2019, effective 01/01/2020 Renumbered from 332-025-0050 by DEM 5-2011, f. & cert. ef. 9-26-11 DEM 6-2010, f. 12-30-10, cert. ef. 1-1-11 DEM 1-2004, f. 6-29-04, cert. ef. 7-1-04 DEM 1-2002, f. 2-25-02 cert. ef. 3-1-02 DEM 1-2001(Temp), f. & cert. ef. 10-1-01 thru 3-29-02

This rule cites

No citations extracted.

Cited by

Official source: https://secure.sos.state.or.us/oard/